Impact of 17β-HSD12, the 3-ketoacyl-CoA reductase of long-chain fatty acid synthesis, on breast cancer cell proliferation and migration

Abstract

Metabolic reprogramming of tumor cells involves upregulation of fatty acid (FA) synthesis to support high bioenergetic demands and membrane synthesis. This has been shown for cytosolic synthesis of FAs with up to 16 carbon atoms. Synthesis of long-chain fatty acids (LCFAs), including ω-6 and ω-3 polyunsaturated FAs, takes place at the endoplasmic reticulum. Despite increasing evidence for an important role of LCFAs in cancer, the impact of their synthesis in cancer cell growth has scarcely been studied. Here, we demonstrated that silencing of 17β-hydroxysteroid dehydrogenase type 12 (17β-HSD12), essentially catalyzing the 3-ketoacyl-CoA reduction step in LCFA production, modulates proliferation and migration of breast cancer cells in a cell line-dependent manner. Increased proliferation and migration after 17β-HSD12 knockdown were partly mediated by metabolism of arachidonic acid towards COX2 and CYP1B1-derived eicosanoids. Decreased proliferation was rescued by increased glucose concentration and was preceded by reduced ATP production through oxidative phosphorylation and spare respiratory capacity. In addition, 17β-HSD12 silencing was accompanied by alterations in unfolded protein response, including a decrease in CHOP expression and increase in eIF2α activation and the folding chaperone ERp44. Our study highlights the significance of LCFA biosynthesis for tumor cell physiology and unveils unknown aspects of breast cancer cell heterogeneity.

Polyunsaturated fatty acid biosynthesis pathway determines ferroptosis sensitivity in gastric cancer

“…S2B). The >180-kDa band might be the aggregated form of the ELOVL5 proteins, as suggested in a previous study showing that this protein aggregates during boiling (29). Similarly, we could detect ELOVL5 protein at ∼30 kDa in all mesenchymal-type GCs using unboiled lysates (Fig.…”

Genome-Wide Association Study Identifies Genetic Loci Associated With Fat Cell Number and Overlap With Genetic Risk Loci for Type 2 Diabetes

“…HSD17B12 encodes an enzyme that controls elongation of long-chain fatty acids. Knockdown of HSD17B12 has been reported to either stimulate or inhibit cell proliferation ( 39 ). PEPD encodes pepdidase C, which cleaves di- and tripeptides containing carboxyl-terminal proline and is involved in protein degradation.…”

Emerging roles of polyunsaturated fatty acid synthesis pathway in colorectal cancer

“… (Nagasaki et al 2009 ) Knockdown of HSD17B12 increased proliferation and migration of MCF7 and MDA-MB-453 cells. (Tsachaki et al 2020 ) Knockdown of HSD17B12 decreased proliferation of SUM159 cells. (Tsachaki et al 2020 ) Ovarian cancer HSD17B12 expression in cancer tissue was suggested as a marker of poor prognosis.…”

“… (Tsachaki et al 2020 ) Knockdown of HSD17B12 decreased proliferation of SUM159 cells. (Tsachaki et al 2020 ) Ovarian cancer HSD17B12 expression in cancer tissue was suggested as a marker of poor prognosis. Silencing of HSD17B12 in cancer cell lines resulted in growth inhibition and increased apoptosis.…”